10-YEAR FOLLOW-UP OF SUBJECTS WITH IMPAIRED GLUCOSE-TOLERANCE - PREVENTION OF DIABETES BY TOLBUTAMIDE AND DIET REGULATION

被引：260

作者：

SARTOR, G

SCHERSTEN, B

CARLSTROM, S

MELANDER, A

NORDEN, A

PERSSON, G

机构：

[1] UNIV LUND,MALMO GEN HOSP,DEPT CLIN PHARMACOL,S-21401 MALMO,SWEDEN

[2] DEPT COMMUNITY CARE SERV,DALBY,SWEDEN

来源：

DIABETES | 1980年 / 29卷 / 01期

关键词：

D O I：

10.2337/diabetes.29.1.41

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：41 / 49

页数：9

共 40 条

[1]

BARNES AJ, 1974, LANCET, V2, P69

[2]

BOSHELL BR, 1967, TOLBUTAMIDE AFTER 10, P286

[3] SETTLING UGDP CONTROVERSY [J].

BRADLEY, RF ;

DOLGER, H ;

FORSHAM, PH ;

SELTZER, H .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 232 (08) :813-817

[4]

BRANDT L, 1964, ACTA MED SCAND, V176, P555

[5]

CARLSTROM S, 1971, ACTA MED SCAND, V189, P415

[6] HYPERGLYCEMIA - A RISK FACTOR IN CORONARY HEART DISEASE [J].

EPSTEIN, FH .

CIRCULATION, 1967, 36 (04) :609-+

[7] DRUG COMPLIANCE IN DIABETICS [J].

ESHELMAN, FN .

BRITISH MEDICAL JOURNAL, 1978, 1 (6112) :581-581

[8] APPRAISAL OF EXTRAPANCREATIC ACTIONS OF SULFONYLUREAS [J].

FELDMAN, JM ;

LEBOVITZ, HE .

ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (03) :314-+

[9]

FELDMAN R, 1973, ADV METABOLIC DIS S2, V2, P557

[10] BASAL NORMOGLYCEMIA ATTAINED WITH CHLORPROPAMIDE IN MILD DIABETES [J].

HOLMAN, RR ;

TURNER, RC .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (05) :539-547

← 1 2 3 4 →